CD79A and infection: This study sought to evaluate serum IgG and IgA responses up to 12 months post-infection and 9 months post-COVID-19-vaccination, compare differences in antibody magnitude between individuals based on SARS-CoV-2 infection status, and characterize serum SARS-CoV-2 neutralization potential over time.